RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families (Q57083786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

title

RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference

Sara Gutiérrez-Enríquez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Gemma Montalban

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Judith Balmaña

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Ángel Carracedo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Orland Diez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

author name string

Ana Blanco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Marta Santamariña

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Sandra Bonache

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

Ana Vega

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

language of work or name

English

0 references

publication date

3 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

11 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

volume

147

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

page(s)

133-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

11 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Identification of the breast cancer susceptibility gene BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

CHEK2 contribution to hereditary breast cancer in non-BRCA families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Breast and other cancers in families with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Identification and purification of two distinct complexes containing the five RAD51 paralogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Mutation of the RAD51C gene in a Fanconi anemia-like disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

RAD51C is a susceptibility gene for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Germline RAD51C mutations confer susceptibility to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

RAD51C germline mutations in breast and ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

RAD51C germline mutations in breast and ovarian cancer cases from high-risk families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Mutation screening of RAD51C in high-risk breast and ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Mutation screening of RAD51C in male breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Germline mutations in RAD51C in Jewish high cancer risk families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-014-3078-4

10.1007/S10549-014-3078-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25086635%20AND%20SRC:MED&resulttype=core&format=json

11 March 2020

1 reference